PT Kalbe Farma Tbk. (IDX:KLBF)

PT Kalbe Farma Tbk. Revenue

PT Kalbe Farma Tbk. had revenue of 9.50T IDR in the quarter ending September 30, 2026, with 6.58% growth. This brings the company's total for the last twelve months to 38.31T, up 11.44% year-over-year. In the year 2025, PT Kalbe Farma Tbk. had annual revenue of 35.32T with 8.27% growth. That makes PT Kalbe Farma Tbk. the 4,809th largest company in the world by revenue and 39th in Indonesia.

• Revenue (ttm): 38.31T
• Revenue Growth: +11.44%
• P/S Ratio: 0.86
• Revenue / Employee: 2.99B
• Employees: 12,806
• Market Cap: 33.03T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Distribution and Logistic 12.21T 34.6%
• Prescription Pharmaceutical 10.24T 29.0%
• Nutritionals 8.05T 22.8%
• Consumer Health 4.83T 13.7%

By Geography

Chart

• Indonesia 32.70T 92.6%
• Exports 2.62T 7.4%

Fiscal year ended Dec 31, 2025 See the full PT Kalbe Farma Tbk. breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.32T	2.70T	8.27%
Dec 31, 2024	32.63T	2.18T	7.16%
Dec 31, 2023	30.45T	1.52T	5.24%
Dec 31, 2022	28.93T	2.67T	10.18%
Dec 31, 2021	26.26T	3.15T	13.62%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error